- Home
- APC vs ORIC Comparison
APC vs ORIC Comparison
Compare APC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APC | ORIC |
|---|---|---|
| Founded | 2025 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 920.0M | 837.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | APC | ORIC |
|---|---|---|
| Price | $20.64 | $8.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $21.75 | $19.73 |
| AVG Volume (30 Days) | 135.3K | ★ 1.3M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | ★ 10.99% | N/A |
| EPS Growth | N/A | ★ 19.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.47 | N/A |
| Revenue Next Year | $4.20 | N/A |
| P/E Ratio | $25.80 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.08 | $4.65 |
| 52 Week High | $21.72 | $14.93 |
Technical Indicators
Market Signals| Indicator | APC | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 66.90 | 31.58 |
| Support Level | $17.43 | $7.90 |
| Resistance Level | N/A | $13.89 |
| Average True Range (ATR) | 0.67 | 0.50 |
| MACD | 0.24 | -0.10 |
| Stochastic Oscillator | 70.38 | 4.87 |
Price Performance
Historical ComparisonAbout APC ARKO Petroleum Corp. Class A Common Stock
Arko Petroleum Corp is a fuel distribution company. It operates through three reportable segments: i) Wholesale: Distributes fuel to gas stations, sub-wholesalers, and bulk purchasers, typically under long-term contracts on a cost-plus or consignment basis. ii) Fleet Fueling: Operates proprietary and third-party cardlock locations serving commercial and municipal fleets, and earns commissions from proprietary fuel card sales. iii) GPMP: Supplies fuel to ARKO Retail Sites at cost plus a fixed margin, charges fixed fees to certain sites. The company generates the majority of revenue from the Wholesale segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.